Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Yamamoto

Showing results (101-110 of 161) with videos related to

Pageof 17
Sort By:
Metabolism: Clinical and Experimental|March 7, 2001
Differential effects of obesity with and without hyperinsulinemia on plasma lipoprotein(a) concentrations in menC Posadas-Romero, A Hernández-Ono, J Zamora-González, et al.
Journal of Chronic Diseases|January 1, 1983
A pharmaceutical profile of diabetic patientsM Rendell, W D Lassek, D A Ross, et al.
Diabetes Care|December 1, 1994
The prevalence of NIDDM and associated coronary risk factors in Mexico CityC Posadas-Romero, L Yamamoto-Kimura, I Lerman-Garber, et al.
Boletin Medico Del Hospital Infantil De Mexico|June 1, 1992
[The prevalence of elevated arterial pressure and risk factors in adolescents in the Federal District of Mexico]L Yamamoto-Kimura, A Fajardo-Gutiérrez, R Méndez-Vargas, et al.
Blood|February 7, 2009
Alternative pre-mRNA splicing switches modulate gene expression in late erythropoiesisMiki L Yamamoto, Tyson A Clark, Sherry L Gee, et al.
International Journal of Cancer|April 9, 1998
TP53 genetic alterations in head-and-neck carcinomas from BrazilM A Nagai, E C Miracca, L Yamamoto, et al.
Environmental Mutagenesis|January 1, 1981
A standardized procedure for quantification of the Ames Salmonella/mammalian-microsome mutagenicity testW L Belser, S D Shaffer, R D Bliss, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1986
Pharmacokinetics of superselective intra-arterial and intravenous [11C]BCNU evaluated by PETJ L Tyler, Y L Yamamoto, M Diksic, et al.
No to Shinkei = Brain and Nerve|January 1, 1985
[Cerebral blood flow, cerebral oxygen metabolism, cerebral glucose metabolism, and tissue pH in human acute cerebral infarction using positron emission tomography]S Kitamura, A Kato, Y L Yamamoto, et al.
Genetics and Molecular Biology|December 16, 2014
c.G2114A MYH9 mutation (DFNA17) causes non-syndromic autosomal dominant hearing loss in a Brazilian familyVitor G L Dantas, Karina Lezirovitz, Guilherme L Yamamoto, et al.
Pageof 17

Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
Metabolism: Clinical and Experimental|March 7, 2001
Differential effects of obesity with and without hyperinsulinemia on plasma lipoprotein(a) concentrations in menC Posadas-Romero, A Hernández-Ono, J Zamora-González, et al.
Journal of Chronic Diseases|January 1, 1983
A pharmaceutical profile of diabetic patientsM Rendell, W D Lassek, D A Ross, et al.
Diabetes Care|December 1, 1994
The prevalence of NIDDM and associated coronary risk factors in Mexico CityC Posadas-Romero, L Yamamoto-Kimura, I Lerman-Garber, et al.
Boletin Medico Del Hospital Infantil De Mexico|June 1, 1992
[The prevalence of elevated arterial pressure and risk factors in adolescents in the Federal District of Mexico]L Yamamoto-Kimura, A Fajardo-Gutiérrez, R Méndez-Vargas, et al.
Blood|February 7, 2009
Alternative pre-mRNA splicing switches modulate gene expression in late erythropoiesisMiki L Yamamoto, Tyson A Clark, Sherry L Gee, et al.
International Journal of Cancer|April 9, 1998
TP53 genetic alterations in head-and-neck carcinomas from BrazilM A Nagai, E C Miracca, L Yamamoto, et al.
Environmental Mutagenesis|January 1, 1981
A standardized procedure for quantification of the Ames Salmonella/mammalian-microsome mutagenicity testW L Belser, S D Shaffer, R D Bliss, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1986
Pharmacokinetics of superselective intra-arterial and intravenous [11C]BCNU evaluated by PETJ L Tyler, Y L Yamamoto, M Diksic, et al.
No to Shinkei = Brain and Nerve|January 1, 1985
[Cerebral blood flow, cerebral oxygen metabolism, cerebral glucose metabolism, and tissue pH in human acute cerebral infarction using positron emission tomography]S Kitamura, A Kato, Y L Yamamoto, et al.
Genetics and Molecular Biology|December 16, 2014
c.G2114A MYH9 mutation (DFNA17) causes non-syndromic autosomal dominant hearing loss in a Brazilian familyVitor G L Dantas, Karina Lezirovitz, Guilherme L Yamamoto, et al.
Pageof 17